Skip links

Nexviazyme® (avalglucosidase alfa-ngpt)

Full Name Nexviazyme® (avalglucosidase alfa-ngpt)
Drug Nexviazyme
Manufacturer Sanofi Genzyme
Route of Administration Intravenous
Site of Care Home or Healthcare Facility
Approved Indication The treatment of patients 1 year of age and older with late-onset Pompe disease (lysosomal acid alpha-glucosidase [GAA] deficiency)
Disease Pompe Disease
Therapeutic Area Neurology, Genetics
Enrollment Form Link Nexviazyme Enrollment Form Link
Phone Number 800-240-9572
Fax Number 877-220-7581
Product Website